Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
Canepa Healthcare, now known as Evidity Health Capital, is a late-stage venture capital and growth equity firm specializing in medical devices, in vitro diagnostics, and disruptive digital health. The firm focuses on private companies with commercialized products that require growth capital to achieve profitability. Evidity Health Capital was founded in 2014 and rebranded in late 2019 to better reflect its value-focused, evidence-based, business-building investment approach.
Portfolio
No portfolio companies in this dataset yet.
Investment activity
1 portfolio exit on record.
Portfolio by sector
Health Tech & Life Sciences1
Q&A
- What is Canepa Healthcare's primary sector focus?
- Canepa Healthcare primarily focuses on the Health Tech & Life Sciences sector, with all of its portfolio companies and exits concentrated in this area.
- Canepa Healthcare has had any notable exits?
- Yes, Canepa Healthcare had an exit in April 2020 when its portfolio company, Dune Medical Devices, was acquired by Dilon Technologies.
- Which company is a key part of Canepa Healthcare's portfolio?
- Dune Medical Devices, a company focused on real-time cancer detection, is a key portfolio company for Canepa Healthcare. It was founded in 2002 and raised $53.8M before its acquisition.
- What is the typical investment range for Canepa Healthcare?
- Canepa Healthcare typically invests in the range of $12.3M to $21M.
- When was Canepa Healthcare founded?
- Canepa Healthcare was created in May 2019.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2014 |
|---|